Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow

Ivan Martin, Anita Muraglia, Giuliano Campanile, Ranieri Cancedda, Rodolfo Quarto

Research output: Contribution to journalArticlepeer-review

Abstract

We have investigated the effects of different growth factors on the proliferation and osteogenic potential of primary cultures of human bone marrow stromal cells (BMSC). Fibroblast growth factor (FGF)-2 was the most effective in promoting growth of these cells in vitro. The size of colonies formed in clonal conditions was approximately 2.5 times larger in presence of FGF-2. Also the morphology of BMSC was affected: cells cultured in 10% FCS alone became flattened, whereas FGF-2 expanded cells maintained a fibroblast- like elongated phenotype. Levels of alkaline phosphatase activity in BMSC expanded with FGF-2 were significantly lower (56%) than control and, after stimulation with ascorbic acid, βGlycerophosphate and dexamethasone, FGF-2 expanded BMSC deposited approximately 3-fold more mineralized matrix than control cells. We have assessed osteogenicity of BMSC on hydroxyapatite porous scaffolds (bioceramics) by an ectopic bone formation assay. FGF-2 expanded BMSC yielded a higher bone formation (>20-fold) than control cells. We conclude that FGF-2, promoting BMSC proliferation, maintains cells in a more immature state allowing in vitro expansion of human osteoprogenitors which, associated with bioceramics, can differentiate in vivo and form bone tissue.

Original languageEnglish
Pages (from-to)4456-4462
Number of pages7
JournalEndocrinology
Volume138
Issue number10
DOIs
Publication statusPublished - 1997

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow'. Together they form a unique fingerprint.

Cite this